Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRISIL Ltd. Regulatory Filings 2021

Jul 21, 2021

58999_rns_2021-07-21_cac97369-d890-49fa-addd-15fc3953b188.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [596 x 83] intentionally omitted <==

July 21, 2021

Listing Department National Stock Exchange of India Ltd. Exchange Plaza, 5[th] floor Plot No. C/1, G Block Bandra-Kurla Complex Bandra (East) Mumbai 400 051

Listing Department BSE Limited P J Towers Dalal Street Mumbai 400 001

Dear Sirs,

Sub.: Intimation of Analyst Meet

Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that analyst meetings are scheduled as per the details given below:

elow:
Date Interaction with Meeting Type Place
26-July-21 Rare Enterprises Call Mumbai
27-July-21 IIFLCAP Call Mumbai

Please note that the above is subject to change, if any.

Kindly take this communication on record.

Yours faithfully,

For CRISIL Limited

==> picture [102 x 43] intentionally omitted <==

Minal Bhosale

Company Secretary

ACS 12999

CRISIL Limited

Corporate Identity Number: L67120MH1987PLC042363

Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400076. Phone: +91 22 3342 3000 | Fax: +91 22 3342 3001 www.crisil.com